Reverse-turn mimetics and methods relating thereto

Details Reverse-turn mimetics and methods relating thereto Reverse-turn mimetics and methods relating thereto

2006-03-07

2006-03-07

Celsa, Bennett (Department: 1639)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C514S250000, C514S230500, C435S007100, C436S518000, C544S014000, C544S095000, C544S345000, C544S350000

Reexamination Certificate

active

07008941

ABSTRACT:
Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed:wherein A, B, X, R1, and R5are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.

REFERENCES:
patent: 5440013 (1995-08-01), Kahn
patent: 5545568 (1996-08-01), Ellman
patent: 5929237 (1999-07-01), Kahn
patent: 6013458 (2000-01-01), Kahn et al.
patent: 6184223 (2001-02-01), Kahn et al.
patent: 6294525 (2001-09-01), Stasiak et al.
patent: 6413963 (2002-07-01), Kahn et al.
patent: 6440955 (2002-08-01), Stasiak et al.
patent: WO 94/03494 (1994-02-01), None
patent: WO 97/15557 (1997-05-01), None
patent: WO 98/49168 (1998-11-01), None
patent: WO 01/00210 (2001-01-01), None
patent: WO 01/16135 (2001-03-01), None
Abignente et al., “Research on heterocyclic compounds. XVI 2-Methylimidazo[1,2-a]pyrazine-3-carboxylic acids,”Chemical Abstracts Database, Accession No. 103:87841, 1985.
Barrow and Sun, “Spiroquinazolone, a novel substance P inhibitior with a new carbon skeleton, isolated from Aspergillus flavipes,”Chemical Abstracts Database, Accession No.. 121: 129499, 1994.
Cutler et al., “Cinereain: a novel metabolitc with plant growth regulating properties fron Botrytis cinerea,”Chemical Abstracts Database, Accession No. 109:165645, 1988.
Dennin et al., “Synthesis of derivatives of pyrazino[1,2-a]pyrimidin-4-ones,”Chemical Abstracts Database, Accession No. 114:164135, 1991.
Faehnle and Rothe, “Syntheses and reactions of peptide cyclols, ”Chemical Abstracts Database, Accession No. 102:7061, 1985.
Gatta et al., “New [f]-fused xanthines: synthesis of 1,3-dipropyl-1H, 3H-pyrazino, pyrido, pyrimido and pyrrolo [2,1-f]purine-2,4-diones,”Chemical Abstracts Database: 121:57444, 1994.
Hackh's Chemical Dictionary, Grant, Julius (ed.), pp. 332, 532 and 656, 1944.
Kadam et al., “Fermentative manufacture of multiple drug resistance-attenuating ardeemins,”Chemical Abstracts Marpat Database, Accession No. 121:7435, 1994.
Kappe and Kappe, “Cross-conjugated and pseudo-cross-conjugated mesomeric betaines. XVII. Bicyclic mesoinonic pyrimidines with cardiovascular activity, ”Chemical Abstracts Database,Accession No. 116:83634, 1992.
Lam et al., “A new type of synthetic peptide library for identifying ligand-binding activity,”Nature 354:82-84, 1991.
Lucente et al., “Synthesis and x-ray crystal structure of a tripeptidic cyclol,”Chemical Abstracts Database, Accession No. 96:69410, 1982.
Lucente et al., “Cyclization of Activated N-Benzyloxycarbonyl-Tripeptides,”Tetrahedron Letters, No. 11, pp. 1009-1012, 1978.
Numata et al., “Structures of cytotoxic substances and new quinazoline derivatives produced by a fungus from a saltwater fish, ”Chemical Abstracts Database, Accession No. 116;210833, 1992.
Okawara et al. “Preparation and hydrogenolysis of fused piperazines by reaction of diamine and triamine derivatives with bezil. Applications to the synthesis of terminal N-monoprotected triamines, ”Chemical Abstracts Database, Accession No. 117:191810, 1992.
Okawara et al., “Simple preparation of terminal N-monoprotected triamines using fused piperazines,”Chemical Abstracts Database, Accession No. 114:101300, 1991.
Penn et al., “Biosynthesis of glyantrypine by Aspergillus clavatus,”Chemical Abstracts Database, Accession No. 117:44249, 1992.
Penn et al., “Glyantrypine, a novel anthranilic acid-containing metabolite of Aspergillus clavatus,”Chemical Abstracts Database, Accession No. 117:127875, 1992.
Pinnen et al., “Cyclization under mild conditions of anthraniloyl and N-methylanthraniloyl dipeptides,”Chemical Abstracts Database, Accession No. 110:76029, 1989.
Pinnen et al., “Ten-membered cyclotripeptides: influence of the ring-flexibility on intramolecular reactions, ”Chemical Abstracts Database, Accession No. 102:132448, 1985.
Rothe et al., “Cyclol formation during tripeptide cyclizations. Synthesis of a secondary cyclotripeptide, cyclo-(D-Phe-L-Pro-L-Pro),”Chemical Abstracts Database, Accession No. 97:56231, 1982.
Rothe et al., “Secondary all-L-cyclotripeptides,”Chemical Abstracts Database, Accession No. 103:215766, 1985.
Sauter et al., “Novel basically substituted pyrimidines and benzothienopyrimidines,”Chemical Abstracts Database, Accession No. 87;84931, 1977.
Tanaka and Narita, “Syntheses of pyrido[2,3-b]pyrazine derivatives,”Chemical Abstracts Database, Accession No. 84:31002, 1976.
Vojkovsky et al., “Solid-Phase Synthesis of Heterocycles Containing an 1-Acyl-3-oxopiperazine Skeleton,”J. Org. Chem. 63: 3162-3163, 1998.

Affiliated with

Also associated with

Rating

Reverse-turn mimetics and methods relating thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reverse-turn mimetics and methods relating thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reverse-turn mimetics and methods relating thereto will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3563071